Correlation Between Vaxcyte and IGM Biosciences

Can any of the company-specific risk be diversified away by investing in both Vaxcyte and IGM Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaxcyte and IGM Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vaxcyte and IGM Biosciences, you can compare the effects of market volatilities on Vaxcyte and IGM Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaxcyte with a short position of IGM Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaxcyte and IGM Biosciences.

Diversification Opportunities for Vaxcyte and IGM Biosciences

0.62

Correlation Coefficient

Vaxcyte  IGM Biosciences

Poor diversification

The 3 months correlation between Vaxcyte and IGM is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Vaxcyte and IGM Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on IGM Biosciences and Vaxcyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaxcyte are associated (or correlated) with IGM Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of IGM Biosciences has no effect on the direction of Vaxcyte i.e., Vaxcyte and IGM Biosciences go up and down completely randomly.

Pair Corralation between Vaxcyte and IGM Biosciences

Given the investment horizon of 90 days Vaxcyte is expected to generate 0.72 times more return on investment than IGM Biosciences. However, Vaxcyte is 1.39 times less risky than IGM Biosciences. It trades about -0.03 of its potential returns per unit of risk. IGM Biosciences is currently generating about -0.06 per unit of risk. If you would invest  7,052  in Vaxcyte on May 4, 2025 and sell it today you would lose (3,750) from holding Vaxcyte or give up 53.18% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Vaxcyte  vs.  IGM Biosciences

Vaxcyte

Risk-Adjusted Performance

Very Weak

Over the last 90 days Vaxcyte has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Vaxcyte is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

IGM Biosciences

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in IGM Biosciences are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable primary indicators, IGM Biosciences is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Vaxcyte and IGM Biosciences

The main advantage of trading using opposite Vaxcyte and IGM Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaxcyte position performs unexpectedly, IGM Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IGM Biosciences will offset losses from the drop in IGM Biosciences' long position.

The idea behind Vaxcyte and IGM Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.